Looking forward to ACDM 2019

Written by Cmed

We’re excited to be participating in the Association for Clinical Data Management’s (ACDM) Annual Meeting this year, hosted in Amsterdam on March 11th-12th. As with any leading industry event, we’re looking forward to meeting fellow professionals to share ideas, learn about changes and new developments, and listen to a wide variety of speakers. The one and a half day event will provide a chance to attend a variety of interesting sessions but more than that, it will be an excellent opportunity to network and share our take on the current challenges within clinical data management.

A recent survey conducted by Pharma Intelligence revealed that among the most pressing issues today are the absence of real-time access to clinical trial data and the fact that 90% of the effort involved in aggregating, cleaning and transforming data is manual. Moreover, over 80% of the respondents considered that incomplete and inconsistent data represents the top issue for regulatory compliance. Lastly, perhaps one of the most important findings was that eSource data is the future - finding ways to clean and manage new forms of data will be the next step in the progress of clinical trials.

The survey was conducted on 155 qualified respondents from biotechs, large pharma companies and CROs, representing a significant voice of the market.

These findings came as no surprise as we see some of these same challenges facing the industry. The current patchwork of often quite dated clinical data systems and the use of separate tools, with inadequate interoperability usually leads to data lag, data errors, process inefficiencies, and regulatory challenges. As well as this, poor management and insight into trial progress and a lack of timely decision making are always a concern.

However, leveraging today’s technologies now offers an opportunity to address many of the principle trial process issues, with significant improvements in time, cost, and the quality of data collected.

That’s why at Cmed we created encapsia®, a powerful clinical data suite that delivers a complete solution to gather and manage data in clinical trials and give true, live insights on trial progress to inform and enhance management decisions.

encapsia allows data to be captured flexibly, for example by mobile direct data capture (eSource), multi-media and web EDC. Data can be viewed live in visual insights and can provide real time analytics of both clinical metrics and trial performance.

Observations and issues can be highlighted, socialized with study stakeholders, actioned, tracked and automatically compiled into clear auditable formats. The encapsia suite is fully compliant with all relevant regulatory standards. The suite has also been designed to easily integrate with existing EDC platforms allowing customers to benefit from selected enhancements without having to displace all incumbent solutions.

We built encapsia for the future of clinical trials. And we’d love to show you more.

To learn more about us and our revolutionary clinical data suite, speak to us at ACDM this March. Louise Holliday and Kirsten Bulpitt will be at the event at booth #7 in Exhibitor Zone A. Both Louise and Kirsten will discuss your clinical trial challenges and also your options.

Or get in touch with us via info@cmedresearch.com.